Your browser doesn't support javascript.
loading
Standardization of Epidemiological Surveillance of Group A Streptococcal Impetigo.
Miller, Kate M; Carapetis, Jonathan R; Cherian, Thomas; Hay, Roderick; Marks, Michael; Pickering, Janessa; Cannon, Jeffrey W; Lamagni, Theresa; Romani, Lucia; Moore, Hannah C; Van Beneden, Chris A; Barth, Dylan D; Bowen, Asha C.
Affiliation
  • Miller KM; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Carapetis JR; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Cherian T; Perth Children's Hospital, Perth, Western Australia, Australia.
  • Hay R; MMGH Consulting, Geneva, Switzerland.
  • Marks M; St John's Institute of Dermatology, King's College London, United Kingdom.
  • Pickering J; Clinical Research Department, Faculty of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Cannon JW; Hospital for Tropical Diseases, University College, London, United Kingdom.
  • Lamagni T; Division of Infection and Immunity, University College London, London, United Kingdom.
  • Romani L; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Moore HC; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Van Beneden CA; Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Barth DD; United Kingdom Health Security Agency, London, United Kingdom.
  • Bowen AC; The Kirby Institute, University of New South Wales Sydney, Sydney, Australia.
Open Forum Infect Dis ; 9(Suppl 1): S15-S24, 2022 Sep.
Article in En | MEDLINE | ID: mdl-36128409
ABSTRACT
Impetigo is a highly contagious bacterial infection of the superficial layer of skin. Impetigo is caused by group A Streptococcus (Strep A) and Staphylococcus aureus, alone or in combination, with the former predominating in many tropical climates. Strep A impetigo occurs mainly in early childhood, and the burden varies worldwide. It is an acute, self-limited disease, but many children experience frequent recurrences that make it a chronic illness in some endemic settings. We present a standardized surveillance protocol including case definitions for impetigo including both active (purulent, crusted) and resolving (flat, dry) phases and discuss the current tests used to detect Strep A among persons with impetigo. Case classifications that can be applied are detailed, including differentiating between incident (new) and prevalent (existing) cases of Strep A impetigo. The type of surveillance methodology depends on the burden of impetigo in the community. Active surveillance and laboratory confirmation is the preferred method for case detection, particularly in endemic settings. Participant eligibility, surveillance population and additional considerations for surveillance of impetigo, including examination of lesions, use of photographs to document lesions, and staff training requirements (including cultural awareness), are addressed. Finally, the core elements of case report forms for impetigo are presented and guidance for recording the course and severity of impetigo provided.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Open Forum Infect Dis Year: 2022 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Open Forum Infect Dis Year: 2022 Document type: Article Affiliation country: Australia
...